MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 18.03.2026
InspireMD P/CF 2011-2026 | NSPR
P/CF Jährlich InspireMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.28 | -3.43 | -3.88 | -0.562 | -1.68 | -1.71 | -0.244 | -0.541 | -0.0442 | -0.0131 | -0.00995 | -0.0462 | -0.219 | -184 | -0.476 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.00995 | -184 | -13.3 |
P/CF anderer Aktien in der Medizinische Geräte
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B |  USA |
 |
AdaptHealth Corp.
AHCO
|
2 | $ 12.93 | 1.02 % | $ 1.75 B | USA |
 |
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | USA |
 |
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-2.82 | $ 0.62 | -1.31 % | $ 38.6 M | USA |
 |
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-4.42 | $ 3.22 | - | $ 121 M |  France |
 |
Cardiovascular Systems
CSII
|
-24.2 | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
-13.2 | $ 11.67 | -0.98 % | $ 330 M | USA |
 |
Globus Medical
GMED
|
16.6 | $ 95.25 | 0.39 % | $ 12.9 B | USA |
 |
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-0.145 | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
15.3 | $ 26.39 | -0.34 % | $ 223 M | USA |
 |
Helius Medical Technologies
HSDT
|
-0.34 | $ 2.28 | 5.56 % | $ 1.39 M | USA |
 |
Second Sight Medical Products
EYES
|
-10.8 | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | USA |
 |
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-25 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-90 | $ 16.41 | 1.36 % | $ 385 M | USA |
 |
Butterfly Network
BFLY
|
-18.4 | $ 5.33 | -0.09 % | $ 1.13 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | USA |
 |
LivaNova PLC
LIVN
|
15 | $ 63.87 | -0.51 % | $ 3.48 B |  Britain |
 |
LENSAR
LNSR
|
-4.81 | $ 5.08 | -0.2 % | $ 60.7 M | USA |
 |
Pulmonx Corporation
LUNG
|
-2.25 | $ 1.28 | 0.79 % | $ 52.1 M | USA |
 |
Delcath Systems
DCTH
|
14.5 | $ 10.97 | 1.2 % | $ 393 M | USA |
 |
IRIDEX Corporation
IRIX
|
-7.85 | $ 1.09 | 2.83 % | $ 18.5 M | USA |
 |
CONMED Corporation
CNMD
|
7.72 | $ 39.18 | 2.08 % | $ 1.22 B | USA |
 |
Inspire Medical Systems
INSP
|
15.1 | $ 55.85 | -0.75 % | $ 1.64 B | USA |
 |
Insulet Corporation
PODD
|
31.9 | $ 191.14 | 0.83 % | $ 13.4 B | USA |
 |
Integer Holdings Corporation
ITGR
|
15.2 | $ 85.95 | -0.06 % | $ 2.99 B | USA |
 |
PAVmed
PAVM
|
-1.12 | $ 9.11 | 1.22 % | $ 6.11 M | USA |
 |
Invacare Corporation
IVC
|
-0.436 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
30.6 | $ 83.94 | -0.37 % | $ 49.1 B | USA |
 |
Sintx Technologies
SINT
|
-0.806 | $ 2.43 | -1.62 % | $ 6.74 M | USA |
 |
MiMedx Group
MDXG
|
10.5 | $ 3.46 | 0.87 % | $ 511 M | USA |
 |
Stryker Corporation
SYK
|
34.6 | $ 328.6 | 0.34 % | $ 126 B | USA |
 |
Tactile Systems Technology
TCMD
|
14.9 | $ 25.34 | 1.08 % | $ 580 M | USA |
 |
Nevro Corp.
NVRO
|
-11 | - | - | $ 217 M | USA |